R
Richard D. Carvajal
Researcher at Columbia University
Publications - 332
Citations - 28287
Richard D. Carvajal is an academic researcher from Columbia University. The author has contributed to research in topics: Melanoma & Medicine. The author has an hindex of 54, co-authored 282 publications receiving 23524 citations. Previous affiliations of Richard D. Carvajal include Cornell University & Kettering University.
Papers
More filters
Journal ArticleDOI
Treatment implications of the emerging molecular classification system for melanoma.
TL;DR: It is suggested that prospective genotyping of patients with melanoma should be used increasingly as the authors work to develop new and effective treatments for this disease.
Journal ArticleDOI
Nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients with advanced solid tumors: Survival and long-term safety in a phase I trial.
Suzanne L. Topalian,Mario Sznol,Julie R. Brahmer,David F. McDermott,David Smith,Scott N. Gettinger,Janis M. Taube,Charles G. Drake,Drew M. Pardoll,John D. Powderly,Richard D. Carvajal,Jeffrey A. Sosman,Michael B. Atkins,Scott J. Antonia,David R. Spigel,Donald P. Lawrence,Georgia Kollia,Ashok Kumar Gupta,Jon M. Wigginton,F. Stephen Hodi +19 more
TL;DR: Long-term safety and efficacy outcomes from a phase I study of nivolumab, a PD-1 blocking mAb, in patients (pts) with advanced solid tumors are presented.
Journal ArticleDOI
Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma
TL;DR: Early survival data in patients with metastatic uveal melanoma are promising when considered alongside historical data, and a randomised study comparing tebentafusp to investigator’s choice of therapy is ongoing.
Journal ArticleDOI
Augmenting advance care planning in poor prognosis cancer with a video decision aid: a preintervention-postintervention study.
Angelo E. Volandes,Tomer T. Levin,Susan F. Slovin,Richard D. Carvajal,Eileen M. O'Reilly,Mary Louise Keohan,Maria Theodoulou,Maura N. Dickler,John F. Gerecitano,Michael J. Morris,Andrew S. Epstein,Anastazia Naka‐Blackstone,Elizabeth Walker-Corkery,Yuchiao Chang,Ariela Noy +14 more
TL;DR: The authors tested whether an educational video on the goals of care in advanced cancer helped patients understand these goals and had an impact on their preferences for resuscitation.
Journal ArticleDOI
Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies.
TL;DR: Although immunotherapy with anti-CTLA-4 and anti-PD-1 agents has dramatically changed the treatment approach to cutaneous melanoma, its success in uveal melanoma has been much more limited.